Compounds with minimum inhibitory concentration (MIC) values in the submicromolar range. Activity against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. Intracellular activity similar to isoniazid and rifampin in a macrophage model of Mtb infection. Synergism with rifampin. Good permeability, moderate rates of metabolism and low risk of drug-drug interactions.